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ABSTRACT

KEYWORDS

Background: Project ECHO (Extension for Community Healthcare Outcomes) trains and mentors primary
care providers (PCPs) in the care of patients with complex conditions. ECHO is a distance education model
that connects specialists with numerous PCPs via simultaneous video link for the purpose of facilitating
case-based learning. This article describes a teleECHO clinic based at the University of New Mexico Health
Sciences Center that is focused on treatment of substance use disorders (SUDs) and behavioral health
disorders. Methods: Since 2005, specialists in treatment of SUDs and behavioral health disorders at Project
ECHO have offered a weekly 2-hour Integrated Addictions and Psychiatry (IAP) TeleECHO Clinic focused on
supporting PCP evaluation and treatment of SUDs and behavioral health disorders. We tabulate the
number of teleECHO clinic sessions, participants, and CME/CEU (continuing medical education/continuing
education unit) credits provided annually. This teleECHO clinic has also been used to recruit physicians to
participate in DATA-2000 buprenorphine waiver trainings. Using a database of the practice location of
physicians who received the buprenorphine waiver since 2002, the number of waivered physicians per
capita in US states was calculated. The increase in waivered physicians practicing in underserved areas in
New Mexico was evaluated and compared with the rest of the United States. Results: Since 2008,
approximately 950 patient cases have been presented during the teleECHO clinic, and more than
9000 hours of CME/CEU have been awarded. Opioids are the substances discussed most commonly (31%),
followed by alcohol (21%) and cannabis (12%). New Mexico is near the top among US states in DATA-2000
buprenorphine-waivered physicians per capita, and it has had much more rapid growth in waivered
physicians practicing in traditionally underserved areas compared with the rest of the United States since
the initiation of the teleECHO clinic focused on SUDs in 2005. Conclusion: The ECHO model provides an
opportunity to promote expansion of access to treatment for opioid use disorder and other SUDs,
particularly in underserved areas.
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Introduction
A model of health care education and mentoring in New Mexico (NM), known as Project ECHO (Extension for Community
Healthcare Outcomes), is attempting to address the inadequate
supply of culturally appropriate and accessible specialty care in
rural and traditionally underserved areas. Established at the
University of New Mexico Health Sciences Center (UNMHSC), Project ECHO is designed to develop capacity for safe
and effective treatment of chronic, common, and complex conditions, while monitoring outcomes to ensure quality of care.
Using multipoint video conferencing technology and clinical
management tools, Project ECHO trains and supports primary
care providers (PCPs) in the community in an attempt to help
them to develop knowledge and self-efﬁcacy in the care of a
variety of complex health conditions that they might not typically have felt prepared to treat.1,2 As a result, these providers
receive support to help them to deliver best-practice care for
such health conditions in federally qualiﬁed health centers

(FQHCs) and other community-based clinics where this specialized care was previously unavailable.
The ECHO model is a distance education model in which
specialists located at a “hub” (which is located in an academic
medical center or more rarely in a public health department or
FQHC) connect via simultaneous video link with numerous
community-based PCPs (the “spokes”) for the purpose of facilitating case-based learning. The model has been proven safe and
effective for teaching PCPs to treat hepatitis C,3 and is being
applied to many other conditions, both nationally and internationally. The ECHO model is based on the principle of demonopolizing medical knowledge, with specialists sharing their
expertise and providing telementorship and guided practice to
help PCPs to deliver high-quality specialized care to patients in
their own communities.4 Project ECHO serves as a model that
other academic medical centers, departments of health, and
primary care teams can build upon to provide complex specialized care to underserved populations.5
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We describe a teleECHO clinic, called the Integrated Addictions and Psychiatry (IAP) TeleECHO Clinic, that is focused
on treatment of substance use disorders (SUDs) and behavioral
health (BH) disorders and has been operating since 2005, in
NM. The teleECHO clinic supports PCPs in treating SUDs,
with a particular focus on opioid use disorders, which are
highly prevalent in NM. Speciﬁc aims of the program include
the use of case-based learning to teach NM primary care teams
to address SUDs, and expansion of patient access to physicians
who have the DATA-2000 waiver to prescribe buprenorphine
for opioid use disorder. This article focuses on aspects of the
teleECHO clinic that are related to SUDs.
The IAP TeleECHO Clinic has aims that are similar to the
federally funded Physician Clinical Support System programs,
in which individual PCPs are connected one to one with addiction specialists for mentorship.6 Key differences include the
small number of specialists who staff the teleECHO clinic and
are able to offer guided practice and telementorship to numerous PCPs simultaneously. Also, the IAP ECHO program has
thus far operated in NM and so has been implemented in one
state rather than nationally.
How does the ECHO model work for SUDs? Recruitment of
health care providers to participate in the addiction teleECHO
clinic was initially accomplished primarily by providing grand
rounds–type presentations in communities around NM at a community hospital or large clinic. These presentations provided
information about the magnitude of the problem of SUDs in various regions of NM and educated participants about the potential
beneﬁts of participating in the IAP TeleECHO Clinic. In recent
years, participants have primarily learned about the teleECHO
program via word of mouth. Participation is free of charge, and
upon contacting the IAP program, participants are provided with
instructions for how to join the teleECHO clinic via video. The
video software platform currently in use by ECHO is Zoom, and
ECHO provides participants with access to a license that allows
numerous simultaneous participants for extended video conferences. Participants download the Zoom software and are then able
to join the teleECHO conference from their personal computer or
mobile device. TeleECHO clinic sessions occur once per week for
2 hours. The hub that participants join by video is located at
UNM-HSC at Project ECHO. The facilitators/specialists of the teleECHO clinic typically include an addiction specialist, a psychiatrist, a licensed clinical social worker with addiction expertise, a
psychiatric nurse or psychiatric nurse specialist, and a community
health worker. Participant learners include physicians (family
medicine, internal medicine, pediatrics, preventive medicine, and
psychiatry) and nonphysicians, including nurses, nurse practitioners, physician assistants, community health workers, counselors, social workers, pharmacists, public health ofﬁcials,
epidemiologists, and administrators.
A typical teleECHO clinic session starts with introductions
of all participants (video, telephonic, and in-person) and
announcements of events of interest, such as local training
opportunities or the opening of new treatment programs. Then
a brief didactic session is offered (30-minute presentation on an
aspect of SUD or BH). This is followed by case presentations.
Cases to be presented are typically submitted by participants in
advance of the teleECHO clinic in a standard case template.
The participant who submits the case gives an oral case
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presentation, in de-identiﬁed form. Clarifying questions are
solicited from video and telephonic participants, and then from
participants at the hub, including facilitator/specialists. Then
the clinic facilitator invites recommendations and suggestions,
and discussion ensues regarding teaching points raised by the
presented case. Finally, recommendations are summarized and
are later transmitted to the presenters electronically or via fax.
Participants who are interested in obtaining no-cost continuing
medical education (CME) or continuing education unit (CEU)
credits must register online at the start of the clinic and then
complete a brief electronic questionnaire at the end of the teleECHO clinic. Discussions vary in length, but complex cases
may be discussed for 30 minutes or more.

Methods
New Mexico’s IAP TeleECHO clinic
Starting in 2005, specialists in SUD and BH treatment at UNMHSC have offered a weekly 2-hour teleECHO clinic for PCPs.
PCPs from around NM have joined the virtual clinic, participated in brief didactic presentations, and presented de-identiﬁed
cases from their own practices for feedback from the network in
order to improve their ability to treat patients with SUDs and
BH disorders. Participation is free of charge, and no-cost CME/
CEU credits are offered to participants. To allow us to evaluate
teleECHO clinics, we obtained approval from the UNM-HSC
Human Research Protections Ofﬁce (protocol 12–617).
We describe the number of teleECHO clinics offered each
year, and the average number of annual participants, number
of cases presented, and number of CME/CEU credits awarded.
We report on the number of unique participants since the start
of 2010, the average total number of teleECHO clinics attended,
and the average duration of engagement in the teleECHO
clinic. We studied cases that were presented during the ﬁrst
4 weeks of each year between 2010 and 2015, and tabulated the
frequency with which individual SUDs were presented and discussed. We report on the core SUD curriculum that is offered
as part of the IAP didactic presentations each year.
Recruitment for buprenorphine training
This teleECHO clinic has also been used to recruit physicians to
participate in the 8-hour DATA-2000 waiver training for prescribing buprenorphine for opioid use disorder. These trainings
are offered by Project ECHO IAP program, with certiﬁcation
provided by the American Association of Addiction Psychiatry
(AAAP) or American Osteopathic Association of Addiction
Medicine (AOAAM). Supporting the availability of medication-assisted treatment (MAT) with buprenorphine has been a
major focus of the teleECHO clinic.
In order to evaluate the possible impact of using the
teleECHO network to recruit for the buprenorphine waiver
courses that we have offered in NM, we obtained data from the
Substance Abuse and Mental Health Services Administration
(SAMHSA) on all DATA-2000 buprenorphine waivers that
have been issued in the United States (US) since 2002, listing
the practice ZIP code and the date of issue of the waiver. In
order to examine the impact of states’ efforts to increase the
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number of buprenorphine-waivered physicians, we ranked
states by how many new buprenorphine waivers had been
granted in their state during each calendar year from 2002 to
2014. We then grouped all waivered physicians by state and
divided by the population of that state, arriving at a “total
buprenorphine-waivered physicians per capita” number. Using
this number, we ranked the states 1 through 50.
We obtained census demographic data at the ZIP code level
(from Zipcodes.com) and used this to evaluate the availability
of buprenorphine-certiﬁed physicians in ZIP codes that are
poor, rural, and in which more than 50% of residents self-identify as American Indian or Alaska Native, Asian American,
Black or African American, Hispanic or Latino, or Native
Hawaiian/Other Paciﬁc Islander. A priori, we deﬁned highpoverty ZIP codes as those in which the average income per
household was less than the US average. Rural ZIP codes were
deﬁned as those with less than 1000 residents per square mile.
We used these criteria as a proxy for underserved areas. We calculated the number of physicians who received the DATA-2000
waiver and who listed their practice address in one of these
underserved ZIP code in the years before and in the years following the initiation of the IAP TeleECHO Clinic. We compared the growth of the supply of waivered physicians in NM
with those outside of NM in these target ZIP codes.

Results
Since 2008, more than 950 patient cases (both SUDs and BH disorders) have been presented during the IAP TeleECHO Clinic.
More than 9000 hours of CME/CEU have been awarded for participation. An average of 147 participants join the teleECHO clinic
each year. Since January 1, 2010, 654 unique participants attended
at least 1 clinic (many of them national and international visitors
to the ECHO Institute); 285 participants have attended more than
1 session. The maximum number of clinics that any individual

Table 1. Substance use disorder didactic curriculum from the integrated addictions and psychiatry (IAP) TeleECHO clinic
Alcohol use disorder
Management of alcohol withdrawal
Opioid use disorder
Management of opioid withdrawal
Tobacco use disorder
Benzodiazepine use disorder
Cannabis use disorder
Synthetic drugs (“bath salts” and “spice”)
Identifying and treating dual-diagnosis patients
Challenging conversations in treatment of substance use disorders
Stigma and stigma-busting
Seeking safety (management of trauma and substance use disorders)
Relapse prevention
Community reinforcement approach (CRA)
Motivational interviewing update
Science of urine drug monitoring

attended was 101, with the average for those attending more than
1 clinic session being 12.4 clinics and the average length of time
between ﬁrst and last clinic being 16.3 months.
SUD cases that were presented during the ﬁrst 4 teleECHO
clinics of each calendar year (2010–2015) were tabulated.
Opioids are the substances that have been presented and
discussed most frequently (31% of total SUD cases), followed by
alcohol (21%) and cannabis (12%). Other substances that were
the focus of discussion in this sample of cases included, in
descending order of frequency, cocaine, carisoprodol, benzodiazepines, tobacco, methamphetamine, and dextromethorphan.
For the brief didactic presentations, a set of core topics on
treatment of SUDs is repeated annually (Table 1), along with
presentations on BH disorders and other topics suggested by
the particular cases that are presented.
The ECHO model has allowed for rapid dissemination of
new research ﬁndings and epidemiologic trends. Examples
include rapid spread of information over the teleECHO network regarding purpura associated with cocaine that is

Figure 1. States ranked by number of new buprenorphine-waivered physicians per capita in each state per year, before and after the start of the Integrated Addictions
and Psychiatry (IAP) TeleECHO Clinic in 10/2005; and states ranked by total number of buprenorphine-waivered physicians per capita (2014).
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adulterated with levamisole; real-time sharing of information
about overdose deaths attributable to heroin adulterated
with fentanyl; publicizing and encouraging the use of the
NM Prescription Monitoring Program; and disseminating
emerging data on the appropriate use of buprenorphinemetabolite testing.
Since 2006, when only 36 NM physicians were listed as
buprenorphine-waivered in the federal database, more than
375 NM physicians have participated in DATA-2000 buprenorphine waiver trainings offered by Project ECHO IAP program (with certiﬁcation provided by AAAP or AOAAM). In
addition to the curriculum required by these organizations, the
ECHO trainings include a patient panel, a provider panel, and
training in harm reduction (educating patients about syringe
exchange and reversal of overdose). Physicians were recruited
for these trainings through the teleECHO network and came
from all areas of the state.
New Mexico now has more buprenorphine-waivered physicians per capita than all but 3 other US states (Figure 1); the
states of Vermont, Maine, Massachusetts, and New Mexico were
the top-ranked states in number of waivers per capita as of
2014. Prior to the start of the ECHO IAP program in 2005, NM
ranked 13th nationally in waivered physicians per capita (data
not shown). In addition, the number of waivered physicians per
capita who practice in underserved areas has increased more
rapidly in NM than in the US overall since 2005 (Figure 2).

Discussion
The ECHO model has provided a platform to reach hundreds
of NM PCPs over the past decade and to engage them in casebased learning about the diagnosis and treatment of SUDs.
The applied, case-based nature of the teaching in the
teleECHO clinic is designed to promote rapid incorporation of
new information into clinical practice. It also provides a mechanism to disseminate information that has time-sensitive safety
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implications, such as an increase in overdose risk caused by
new availability of a more potent street-drug formulation.
Participants in ECHO cite the opportunity to learn up-todate information and diminished professional isolation as
important motivators for participation in teleECHO clinics.2,5 Potential barriers to participation include lack of reimbursement for participation in teleECHO clinics, decreased
clinical productivity caused by time allocated to teleECHO
participation (which may in turn have implications for PCP
income), and, in the case of the IAP TeleECHO Clinic, hesitation on the part of PCPs or administrators to engage in
treatment of addiction due to stigma or practical barriers.
Access to buprenorphine treatment for opioid use disorder
in the US remains limited, particularly outside of urban areas.7
Recent studies suggest that almost all US states have an inadequate supply of buprenorphine treatment providers to meet
their populations’ need for this type of treatment.8
Efforts are occurring nationally to improve access to
buprenorphine treatment. Use of the IAP TeleECHO Clinic
to recruit physicians to obtain the DATA-2000 waiver to
prescribe buprenorphine has coincided with marked
increases in the numbers of waivered physicians who practice in traditionally underserved areas in NM, and also with
NM achieving one of the highest per capita numbers of
waivered physicians in the US. It is impossible to disentangle the effects of the addiction teleECHO program from the
inﬂuence of national or other state efforts. However, these
increases are notable in light of the fact that NM ranks
below the US average in spending on treatment for BH and
SUDs, unlike the other states that exceed NM in waivered
physicians per capita (Figure 1). In 2005 NM spent an average of $316 per person on BH and SUD treatment, compared with Vermont (VT) $741, Maine (ME) $673,
Massachusettts (MA) $652, and US average $423.9 New
Mexico also has higher proportions of adults who reported
use of illicit drugs in the year prior to being surveyed

Figure 2. Cumulative number of buprenophine-waivered physicians per million population in traditionally underserved ZIP codes in New Mexico versus the United States.
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(2009–2013) than do these other states (NM 3.5%, VT 3.4%,
MA 3.3%, and ME 2.2%).10-13
The teleECHO clinic’s focus on opioid use disorder and
buprenorphine training, certiﬁcation, and support has coincided with enhancement of the capacity to treat opioid use
disorder in NM. Because the teleECHO network reaches
PCPs in remote areas and appeals to physicians who work
with traditionally underserved populations, it may provide
an effective way to reach and recruit these physicians. Use
of a teleECHO clinic to recruit and train PCPs in treatment
of SUDs may be a cost-effective way to create a more highly
trained workforce to address SUDs in traditionally underserved areas.
Use of the ECHO model to focus on SUD diagnosis and
treatment can be replicated nationally and internationally by
academic medical centers and departments of health that seek to
expand SUD treatment capacity in their region. Implementation
of an ECHO program is facilitated by no-cost training and technical support offered by the ECHO Institute (echo.unm.edu).
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